https://finance.yahoo.com/news/prolong-pharmaceuticals-announces-presentation-phase-100000143.html
0
0
Prolong Pharmaceuticals Announces Presentation of Phase 1 Data from HEMERA-1 Clinical Study of PP-007 in Patients with Acute Ischemic Stroke at the Late-Breaking Science Session, ISC 2023 - Yahoo Finance
2/9/23 at 10:00am
Organization
Yahoo Entertainment
Author
Business Wire
Details
52 words
Summarize
Pharmaceuticals & Biotech Health Drugs & Medications Prolong Pharmaceuticals Announces Presentation Prolong Pharmaceuticals HEMERA-1 PP-007 Late-Breaking Science Session Cerebrovascular Accident SOUTH PLAINFIELD ISC 2023 - Yahoo Finance New Jersey
SOUTH PLAINFIELD, N.J., February 09, 2023--Prolong Pharmaceuticals, a clinical stage biopharmaceutical company, today announced that preliminary data from...
Create an account or login to join the discussion